Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Articles by Hussain M, Fizazi K, Saad F, et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2018, 378(26):2465-2474. doi: 10.1056/NEJMoa1800536.
Advertisement
Latest Updated Articles
- Study Summary: Use of Enzalutamide for High-Risk, Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER)
Published: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces “The Great Healthcare Plan,” Proposing Direct Payments, Price Transparency, Insurance Reform
2
MajesTEC-9 Data Add to Accolades for Teclistamab in Multiple Myeloma
3
5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall
4
New Data Shows Clascoterone Plus Adapalene Delivers Effective Acne Control
5
